588 related articles for article (PubMed ID: 12368336)
21. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
[TBL] [Abstract][Full Text] [Related]
22. Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.
Berger C; Xuereb S; Johnson DC; Watanabe KS; Kiem HP; Greenberg PD; Riddell SR
J Virol; 2000 May; 74(10):4465-73. PubMed ID: 10775582
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
[TBL] [Abstract][Full Text] [Related]
24. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
Benz C; Hengel H
Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
26. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
Oresic K; Ng CL; Tortorella D
J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
[TBL] [Abstract][Full Text] [Related]
27. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation.
Park B; Spooner E; Houser BL; Strominger JL; Ploegh HL
J Exp Med; 2010 Aug; 207(9):2033-41. PubMed ID: 20713594
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
Neumann J; Eis-Hübinger AM; Koch N
J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
[TBL] [Abstract][Full Text] [Related]
29. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
[TBL] [Abstract][Full Text] [Related]
30. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
31. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
[TBL] [Abstract][Full Text] [Related]
32. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.
Hesse J; Ameres S; Besold K; Krauter S; Moosmann A; Plachter B
J Gen Virol; 2013 Feb; 94(Pt 2):376-386. PubMed ID: 23100361
[TBL] [Abstract][Full Text] [Related]
33. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
[TBL] [Abstract][Full Text] [Related]
34. Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation.
Cho S; Jun Y
Biochem Biophys Res Commun; 2011 Oct; 413(4):616-22. PubMed ID: 21925141
[TBL] [Abstract][Full Text] [Related]
35. Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I.
van den Boomen DJ; Lehner PJ
Mol Immunol; 2015 Dec; 68(2 Pt A):106-11. PubMed ID: 26210183
[TBL] [Abstract][Full Text] [Related]
36. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
[TBL] [Abstract][Full Text] [Related]
37. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.
Ameres S; Mautner J; Schlott F; Neuenhahn M; Busch DH; Plachter B; Moosmann A
PLoS Pathog; 2013; 9(5):e1003383. PubMed ID: 23717207
[TBL] [Abstract][Full Text] [Related]
38. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional analysis of human cytomegalovirus US3 protein.
Misaghi S; Sun ZY; Stern P; Gaudet R; Wagner G; Ploegh H
J Virol; 2004 Jan; 78(1):413-23. PubMed ID: 14671122
[TBL] [Abstract][Full Text] [Related]
40. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
